Neurological biomarker research is advancing rapidly, but key challenges remain. This whitepaper captures:

• Expert perspectives from academia and biopharma
• Highlighting successes, setbacks, and strategies for translational advancements in Alzheimer’s, Parkinson’s, and MS.

A must-read for researchers navigating the future of precision neurology.

Brought to you by